Wildenthal K, Crie J S, Ord J M, Wakeland J R
Adv Myocardiol. 1985;5:137-44. doi: 10.1007/978-1-4757-1287-2_10.
The mechanisms and regulatory factors involved in cardiac proteolysis are incompletely understood. Agents that interfere with lysosomal function (e.g., chloroquine, leupeptin, methyladenine) cause a 25-30% reduction in the overall rate of protein degradation. In the same hearts, however, the rate of myosin breakdown remains unchanged. Disaggregation of micro-tubules with colchicine is accompanied by a 15% reduction in the rate of degradation of total protein and of myosin. In the same hearts, the degradation of "organellar" protein, including mitochondrial cytochromes, is reduced by over 30%. Thus, it appears that the degradation of different classes of cardiac proteins may be accomplished and regulated by different processes. Lysosomes are important in overall proteolysis, but appear not to be involved in the regulation of myosin breakdown. Microtubules are also involved in the proteolytic process, and appear to be especially important for the breakdown of proteins from mitochondria and perhaps other organelles.
心脏蛋白水解所涉及的机制和调节因子尚未完全明确。干扰溶酶体功能的药物(如氯喹、亮抑酶肽、甲基腺嘌呤)可使蛋白质降解的总体速率降低25% - 30%。然而,在相同的心脏中,肌球蛋白的降解速率保持不变。用秋水仙碱使微管解聚,总蛋白和肌球蛋白的降解速率会降低15%。在相同的心脏中,包括线粒体细胞色素在内的“细胞器”蛋白的降解减少超过30%。因此,不同类别的心脏蛋白的降解似乎可能通过不同的过程来完成和调节。溶酶体在整体蛋白水解中很重要,但似乎不参与肌球蛋白降解的调节。微管也参与蛋白水解过程,并且对于线粒体和可能其他细胞器的蛋白降解似乎尤为重要。